Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-15 Purchase | 2023-08-15 08:00 am | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 20,000 | $0.25 | $5,000 | 36,000 (Direct) | View |
2023-05-10 Purchase | 2023-05-11 4:10 pm | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 8,111 | $1.495 | $12,126 | 8,111 (Direct) | View |
2023-03-10 Purchase | 2023-03-13 4:22 pm | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 13,000 | $0.8025 | $10,433 | 16,000 (Direct) | View |
2022-05-16 Purchase | 2022-05-17 9:50 pm | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 3,000 | $4.54 | $13,620 | 18,722 (Direct) | View |
2021-03-15 Sale | 2021-03-17 8:00 pm | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 20,006 | $16.85 | $337,101 | 225,818 (Direct) | View |
2020-11-10 Sale | 2020-11-13 9:00 pm | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 37,000 | $15.4 | $569,838 | 260,580 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-03 Option Award | 2024-07-08 5:41 pm | 2025-06-19 2034-07-03 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 3,165 | $0 | 42,330 (Direct) | View |
2024-05-23 Option Award | 2024-05-24 4:15 pm | N/A 2034-05-23 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 55,500 | $0 | 68,761 (Direct) | View |
2024-04-18 Option Award | 2024-04-22 8:48 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 4,667 | $0 | 4,667 (Direct) | View |
2023-12-01 Option Award | 2023-12-04 5:29 pm | 2024-12-01 2033-12-01 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 52,858 | $0 | 52,858 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 26,150 | $0 | 34,261 (Direct) | View |
2022-12-29 Option Award | 2022-12-30 4:55 pm | 2023-12-29 2032-12-29 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 33,475 | $0 | 33,475 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 4:13 pm | N/A 2032-05-26 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 41,589 | $0 | 41,589 (Direct) | View |
2021-03-15 Exercise | 2021-03-17 8:00 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 5,250 | $5 | 225,818 (Direct) | View |
2021-03-15 Exercise | 2021-03-17 8:00 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 14,756 | $2.5 | 225,818 (Direct) | View |
2021-03-15 Exercise | 2021-03-17 8:00 pm | 2019-09-26 2028-09-26 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 20,006 | $0 | 225,818 (Direct) | View |
2020-11-10 Exercise | 2020-11-13 9:00 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 37,000 | $2.5 | 260,580 (Direct) | View |
2020-11-10 Exercise | 2020-11-13 9:00 pm | 2019-09-26 2028-09-26 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 37,000 | $0 | 260,580 (Direct) | View |
2020-08-24 Option Award | 2020-08-26 6:18 pm | N/A N/A | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 20,000 | $0 | 159,429 (Direct) | View |
2019-11-29 Option Award | 2019-12-03 7:41 pm | N/A 2029-10-29 | TFF Pharmaceuticals Inc. | TFFP | ROCAMBOLI STEPHEN Director | 3,623 | $0 | 139,429 (Direct) | View |